Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy

Cancer drugs are big money for big pharma

Dan Gorenstein Aug 26, 2013
Share Now on:
HTML EMBED:
COPY
The hot tip in pharmaceuticals: cancer drugs.
 
This morning, drug maker AstraZeneca scooped up a biotech company for its treatments to help the immune system fight cancer.
 
Yesterday, Amgen bought out a firm with a cancer drug that could generate $1 billion dollars in sales by 2015.
 
Imagine for a moment that you are a small biotech firm, and you manufacture drugs to treat cancer. University of Michigan’s Erik Gordon says pharmaceutical giants may soon be knocking.
 
“What’s going on now is there have been so many product failures at big companies where the drugs they are trying to develop themselves haven’t panned out, that they end up going for whoever has a drug that looks pretty good,” says Gordon.
 
According to the firm EvaluatePharma, cancer drugs made up $84 billion in global sales last year, only trailing treatments to the central nervous system.
 
Bloomberg Industries Andrew Berens says cancer drugs are so hot because many primary care diseases, like high blood pressure, have gone generic. And, Berens says companies can charge a premium for cancer treatments.
 
“It’s not a chronic therapy. It’s a life-threatening disease… for a very definitive period of time. So you don’t see payers really pushing back on those types of diseases,” he says.
Berens says that since prices can run $10,000 or more a month, he expects big pharma to snap up as many cancer drugs as it can.

 

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.

Make a good investment!

Looking for a great deal?
Get ALL THREE of our new thank-you gifts when you donate $120.

This is a limited time offer – so act soon!